Welcome new member: de Faire Medical

We are delighted to welcome de Faire Medical to PAGB as new full members.

de Faire Medical is a Swedish bio-research firm who set itself the mission to empower everyone to feel at their best every day. They aim to uncover the full potential of applying microbial solutions to a specific, unique organic substrate, and to obtain preferential targeting of dietary supplements.

de Faire Medical’s first commercially available product is Myrkl, launched in July 2022 in the UK which is now available in more than 20 markets globally.

For further information, visit de Faire Medical’s website.

Related news

Millions set to benefit as Government publish new list of conditions and categories for reclassification

PAGB is pleased to support an announcement shared by the Department of Health and Social Care (DHSC) which issues a list of medical conditions and categories where it is encouraging more reclassification applications to the Medicines and Healthcare products Regulatory Agency (MHRA).

Millions set to benefit as Government publish new list of conditions and categories for reclassification
View all